ABSTRACT NUMBER: ESOC2026A973 POINT-OF-CARE BIOMARKERS TO ESTIMATE EXTENT OF ISCHEMIC DAMAGE IN ACUTE ISCHEMIC STROKE DUE TO LARGE-VESSEL OCCLUSION
Ralph Nuhay, Catherine Brassard, Julien Paul, David Chiasson-Ricard, Timothé Langlois-Thérien, Laura Gioia · 2026
Read ABSTRACT NUMBER: ESOC2026A973 POINT-OF-CARE BIOMARKERS TO ESTIMATE EXTENT OF ISCHEMIC DAMAGE IN ACUTE ISCHEMIC STROKE DUE TO LARGE-VESSEL OCCLUSION by Ralph Nuhay, Catherine Brassard, Julien Paul, David Chiasson-Ricard, Timothé Langlois-Thérien, Laura Gioia (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146704.txt.
Description
Ralph Nuhay and five colleagues tested whether fast blood tests can show how much brain damage a major stroke has caused. Two proteins, GFAP and UCH-L1, rise when brain cells are hurt. Quick tests for them are sold for head injury care. The team checked them against brain scans in stroke patients.
The study covered one hundred two patients who reached the emergency room within a day of stroke onset. Those with wide damage on their scans had higher GFAP levels. But the test sorted patients only modestly well. The second protein showed no clear gap between groups. Neither protein changed much with time since the stroke began. The authors say these blood tests may add a little to scans, but cannot replace them.
Catalog record
| CREATOR | Ralph Nuhay, Catherine Brassard, Julien Paul, David Chiasson-Ricard, Timothé Langlois-Thérien, Laura Gioia |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |